Qingzhe Wu
Zhejiang Provincial Key Laboratory For Cancer Molecular Cell Biology
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Oncogenic EGFR rewires STING-TBK1 signalosomes to license DNA damage tolerance in NSCLC.
Journal: The EMBO journal
Published: October 19, 2025
Unraveling the intricacies of small cell lung cancer: FAK splicing variants as a new feature and therapeutic vulnerability of small cell lung cancer.
Journal: MedScience
Published: September 13, 2025
Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer.
Journal: Frontiers in oncology
Published: July 01, 2025
Author Correction: Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer.
Journal: Cell discovery
Published: December 20, 2024
Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer.
Journal: Cell discovery
Published: September 27, 2023
Distinct Regulation of ASCL1 by the Cell Cycle and Chemotherapy in Small Cell Lung Cancer.
Journal: Molecular cancer research : MCR
Published: May 25, 2023
YAP drives fate conversion and chemoresistance of small cell lung cancer.
Journal: Science advances
Published: October 01, 2021
MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Journal: The Journal of biological chemistry
Published: October 09, 2020
HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity.
Journal: Nature cell biology
Published: November 22, 2018
Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion.
Journal: The EMBO journal
Published: March 25, 2018
Last Updated: 09/26/2026